-
Cognitive Impairment Following Ischemic and Hemorrhagic Stroke
Published May 2023
Affirmed by the AAN Institute Board of Directors on May 18, 2023
-
Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
Published May 2019
Affirmed by the AAN Institute Board of Directors on May 24, 2019.
-
Consensus-based Care Recommendations for Children with Myotonic Dystrophy Type 1
Published July 2019
Affirmed by the AAN Institute Board of Directors on July 17, 2019. A quick-reference guide is available at https://www.myotonic.org/clinical-resources.
-
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease
Published March 2018
Affirmed by the AAN Institute Board of Directors on June 6, 2018.
-
Treatment and Outcomes of Cervical Artery Dissection in Adults
Published February 2024
Affirmed by the AAN Institute Board of Directors on February 16, 2024.
-
Updated Nomenclature of Delirium and Acute Encephalopathy: Statement of Ten Societies
Published February 2020
Affirmed by the AAN Institute Board of Directors on December 19, 2018.
-
Vascular Neurology Considerations for Antiamyloid Immunotherapy
Published December 2024
Affirmed by the AAN Quality Committee on November 5, 2024.
-
Updated Appropriate Use Criteria for Amyloid and Tau PET
Published January 2025
Affirmed by the AAN Quality Committee on February 1, 2025.
-
Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention: A Systematic Review for the 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
Published May 2021
Affirmed by the AAN Institute Board of Directors.
-
An Updated Definition of Stroke for the 21st Century
Published May 2013
Affirmed by the AAN Institute Board of Directors on January 17, 2012.
-
Assessment Scales for Disorders of Consciousness: Evidence-Based Recommendations for Clinical Practice and Research
Published December 2010
Affirmed by the AAN.
-
Identifying Best Practices to Improve Evaluation and Management of In-Hospital Stroke
Published February 2022
Affirmed by the AAN Institute Board of Directors on November 11, 2020.
-
International Consensus Guidance for Management of Myasthenia Gravis
Published July 2016
Developed by the Myasthenia Gravis Foundation of America. Affirmed by the AAN Institute Board of Directors on September 28, 2016.
-
International Consensus Guidance for Management of Myasthenia Gravis
Published November 2020
Affirmed by the AAN Institute Board of Directors on July 14, 2022.
-
Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Benzodiazepine Risks Outweigh Benefits
Published March 2025
Affirmed by the AAN Quality Committee on February 1, 2025.
-
Management of Adults with Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies
Published June 2016
Endorsed by the 好色先生 on November 2, 2016
-
Management of Central Retinal Artery Occlusion
Published March 2021
Affirmed by the AAN Institute Board of Directors on March 18, 2021.
-
Management of Inherited CNS Small Vessel Diseases: The CADASIL Example
Published August 2023
Affirmed by the AAN Quality Committee on July 15, 2023.
-
Management of Stroke in Neonates and Children
Published January 2019
Affirmed by the AAN Institute Board of Directors on September 26, 2018.
-
Management of Brain Arteriovenous Malformations
Published June 2017
Affirmed by the AAN Institute Board of Directors on September 19, 2016.
Questions?
Email guidelines@aan.com
Call (800) 879-1960 or (612) 928-6000 (international)